• Home
  • News
  • Portfolio News
  • Emovi is Accelerating its Growth Through a 15M$ Series C Investment Led by TVM Capital Life Science

Emovi is Accelerating its Growth Through a 15M$ Series C Investment Led by TVM Capital Life Science

02Apr

Emovi is Accelerating its Growth Through a 15M$ Series C Investment Led by TVM Capital Life Science

Portfolio News
Emovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support its global commercial activities. This 15M$ Series C investment is combined with other capital for a total of 20M$. Read more >>

Share this post

Related Posts

28Jul

Silo Pharma’s partner, Zylo Therapeutics, yielded positive results in reducing neuropathic nerve pain in a small animal study.

Silo Pharma, Inc., a development-stage biopharmaceutical company today announced that its topically administered Ketamine reached a positive end point in... read more
08Nov

Elizabeth Banks On Controlling Her Own Destiny In Hollywood

In this week’s Sunday Sitdown, three-time Emmy-nominated actor Elizabeth Banks talks to Willie Geist about making a career out of... read more
13Jul

Myomo announces center of excellence program

Myomo Inc., a medical robotics company, has created a new program to partner with O&P clinics in the United States... read more
21Sep

eSight™ Assistive Device for Visually Impaired Available for Demonstrations at AAO

Leading vision enhancement platform, eSight, is holding demonstrations of its current medical device model, eSight 4, at the American Academy... read more
02Feb

Looking at the Life Sciences Industry in South Carolina

In recent years, South Carolina has become a hub of sorts for the life sciences and biotech industries. The Palmetto... read more
10Dec

Wasabi Technologies Announces Support in Japan for Veeam Backup for Microsoft Office 365

Wasabi Technologies, the hot cloud storage company, today announced validated interoperability with Veeam® Backup for Microsoft Office 365 with full... read more
17Oct

5 Things I Wish I Knew Before I Became CEO: David Friend, Co-founder & CEO of Wasabi

“Take the negatives that people say about your business plan with a grain of salt. If what you are trying... read more
28Jun

VIA Folio Processes Closing for Myomo, the First Exchange-Traded Reg A+ IPO

VIA Folio is pleased to announce that it has processed the closing of Myomo's Reg A+ IPO, the first of... read more
26Apr

New techology offers area woman the hope of regaining sight

For the past nine years, Charlotte Baker has had one dream. Her vision is restored and her life returns to... read more
03Oct

Platelet Biogenesis and Scaled Biolabs to Collaborate to Optimize Platelet Production Platform

Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of... read more